Exosomes, Peptides and NAD+ IV drips in Paris

Modern regeneration, with clear boundaries.

People often group these three words together online, but they don’t mean the same thing. Cells release tiny vesicles called exosomes, which are being studied for their role in signalling and communication between tissues. Peptides are short chains of amino acids.

They are a wide group that includes both legal, regulated drugs and a big “wellness peptide” market with unclear standards. NAD+ IV drips are intravenous infusions that are advertised as a way to boost energy, speed up recovery, or “support cells.” However, the science, dosing, and tolerability of these products are still being studied and debated.

The reality check: evidence and regulation are not equal

In aesthetic medicine, new “regenerative” trends can move faster than strong clinical data and faster than rules. Different brands and providers can have very different levels of product quality, sourcing, sterility, and clinical evidence. For instance, US regulators have warned about exosome products and said that some uses have caused serious problems.

They also say that there are currently no FDA-approved exosome products. This is a useful safety signal even outside the US because it shows why product origin, medical oversight, and claim restraint are important.

Exosomes: where they fit, and where hype begins

Exosomes are most often talked about in aesthetics as extras to treatments that already promote renewal, like after microneedling or some laser protocols. Preliminary studies and limited clinical reports indicate possible enhancements in skin texture and pore appearance when combined with certain procedures; however, the overall evidence base remains in development and has not yet reached the status of established treatments.

The most important practical problem is not the idea itself, but standardisation. “Exosome” can mean very different things depending on where it comes from and how it is processed.

Peptides: separating medical products from “research” injections

Peptides are not inherently hazardous; numerous essential medications are peptides. The problem is the grey-zone peptide market, where things are sold as “research” compounds but are marketed for people to inject to look younger, lose weight, recover, or improve their appearance.

There are real risks in that space, like not knowing how pure the products are, not knowing how much to take, contamination, and side effects that are hard to predict, especially when people stack different compounds. Dr. Kevin Haddad is strict about what is medically sound and what is not worth the risk.

NAD+ IV drips: what we actually know about tolerability

NAD+ is an important part of human biology, but IV NAD+ therapy is not the same as “supporting NAD biology” in general. In published clinical studies on IV NAD+, participants indicated that tolerability may be a limiting factor, experiencing symptoms such as gastrointestinal discomfort, elevated heart rate, and chest pressure during infusions in certain instances.

This is why it matters if a clinic offers infusion rate, screening, and medical supervision, and why claims should be reasonable and not too high.

Where these options may be considered in an aesthetic plan

People sometimes talk about these methods as extras when they want better “skin quality,” help with recovery, or a gentle program that focuses on health. Dr. Kevin Haddad keeps the use cases narrow and medically sound:

Support for skin quality along with established treatments (not instead of them)
Conversations about recovery support where expectations are low and results are tracked
Only make plans for scalp and hair support after you know the baseline diagnosis and core treatment strategy.
Patients who specifically want “biological support” approaches and understand the results are usually slow to get better.
Times when the most important thing is how the tissue feels, glows, and looks, not how much it lifts or changes shape

Don’t chase trends; that’s the key. It’s picking additions that really fit with a plan without adding extra risk or making promises that can’t be kept.

Safety-first suitability checks

Dr. Kevin Haddad considers screening and boundaries to be part of the treatment itself because these categories can include different products and evidence.

Look over medical history, medications, allergies, and the risk of bleeding or clotting
A clear agreement on the goal (skin quality, contour change, or “energy” claims)
Not using during pregnancy or breastfeeding, and being careful with complicated medical conditions unless medically cleared
Non-negotiable standards for product origin and sterility
A plan for what to do if side effects happen, especially with IV infusions

This is how “regenerative” stays responsible: it is medically supervised, careful, and open about what is known and what is still being learned.

Doctor Observe Exosomes, Peptides and NAD+ IV drips